Medical specialists from Brazil tagged as investigators in clinical trials studying Hypertension, Portal
Total 4 results
-
Andre Luiz M Torres, MDSeen in:
- Rio de Janeiro, Universidade Federal do Rio de Janeiro
Trials:- NCT03720067 (Sub-Investigator)
Conditions: -
Eduardo Sica, MDSeen in:
- RJ, Rio de Janeiro, Hospital Universitário Clementino Fraga Filho / Universidade Federal do Rio de Janeiro (UFRJ)
Trials:- NCT05719857 (Sub-Investigator)
Conditions:- Portal Hypertension;
- Idiopathic Non-Cirrhotic Portal Hypertension;
- Non-Cirrhotic Portal Hypertension;
- Vascular Disorder of Liver;
- Non-Cirrhotic Portal Fibrosis;
- Regenerative Nodular Hyperplasia;
- Incomplete Septal Cirrhosis;
- Obliterative Portal Venopathy;
- Hepatoportal Sclerosis;
- Idiopathic Portal Hypertension
-
Guilherme FM Rezende, MD, PhDSeen in:
- RJ, Rio de Janeiro, Hospital Universitário Clementino Fraga Filho / Universidade Federal do Rio de Janeiro (UFRJ)
Trials:- NCT05719857 (Principal Investigator)
Conditions:- Portal Hypertension;
- Idiopathic Non-Cirrhotic Portal Hypertension;
- Non-Cirrhotic Portal Hypertension;
- Vascular Disorder of Liver;
- Non-Cirrhotic Portal Fibrosis;
- Regenerative Nodular Hyperplasia;
- Incomplete Septal Cirrhosis;
- Obliterative Portal Venopathy;
- Hepatoportal Sclerosis;
- Idiopathic Portal Hypertension
-
Rafael XimenesSeen in:
- Recife, Universidade Federal de Pernambuco
Trials:- NCT04121520 (Principal Investigator)
Conditions:
Clinical Trials on Hypertension, Portal
-
Assistance Publique - Hôpitaux de ParisActive, not recruitingIntrahepatic Non Cirrhotic Portal HypertensionFrance
-
Centro Hospitalar De São João, E.P.E.CompletedClinically Significant Portal HypertensionPortugal
-
University Hospital, ToursCompletedCirrhotic Portal HypertensionFrance
-
Icahn School of Medicine at Mount SinaiNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPortal Hypertension | Clinically Significant Portal HypertensionUnited States
-
University Hospital, GhentCompletedEvaluation of Efficacy and Safety of Somatostatin Used as Inflow Modulator in Liver Transplantation.Liver Transplant With Clinically Significant Portal HypertensionBelgium
-
Universidade Federal do Rio de JaneiroNot yet recruitingPortal Hypertension | Idiopathic Non-Cirrhotic Portal Hypertension | Non-Cirrhotic Portal Hypertension | Vascular Disorder of Liver | Non-Cirrhotic Portal Fibrosis | Regenerative Nodular Hyperplasia | Incomplete Septal Cirrhosis | Obliterative Portal Venopathy | Hepatoportal Sclerosis | Idiopathic Portal...Brazil
-
Ain Shams UniversityCompleted
-
Assiut UniversityUnknownPredicting Liver Cell Failure & Portal Hypertension in LCEgypt
-
University Hospital, BonnCompleted
-
Tanta UniversityCompleted